FDA Authorization Expands Philip Morris’s Zyn Bet, Can It Pay Off?
Philip Morris International Inc. (NYSE:PM) has received FDA authorization for 11 nicotine-pouch products, bolstering its position in the fastest-growing nicotine category in the United States.








